Effect of Bio-activation on Epithelial and Connective Cell Adhesion to Titanium Abutments: Split Mouth Clinical Trial
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The aim of this "in vivo" controlled trial is to assess soft tissue cell adhesion to titanium abutments subjected to different cleaning procedures - no treatment (as they come from the industry), and cleaning by plasma- at an early healing time. In fact, the primary aim is Quantity and Quality of soft tissue adhesion at the microscopic level (e.g Fibronectin, Integrin-actin). The secondary Aim - Clinical parameters and outcomes - BOP, PPD, MBL (Marginal Bone Level to check influence of plasmapp-treated abutments). The null hypothesis of the study was that the cleaning procedure applied to implant abutments has no effect on soft tissue cell adhesion and MBL at an early healing time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2025
CompletedStudy Start
First participant enrolled
July 15, 2025
CompletedFirst Posted
Study publicly available on registry
July 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedJuly 16, 2025
July 1, 2025
4 months
July 5, 2025
July 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
connective tissue coverage
• Coverage was defined as the extent to which the abutment surface was occupied by adherent cells. It reflects the spatial distribution of cells across the surface, providing a measure of surface colonization. Coverage was independently scored on a scale from 1 to 10 by two blinded operators who were unaware of the sample group assignments (i.e., activated vs control). The individual scores were subsequently averaged to obtain a representative value for each parameter per sample.
3 months post-op
Secondary Outcomes (2)
Connective tissue density
3 months post-op
Mean bon loss
1 year post-op
Study Arms (2)
Machined Abutment - control
NO INTERVENTIONThe control group received MUA without plasma treatment.
Plasma abutment - test
EXPERIMENTAL.The MUA allocated to the test group will be placed in a plasma reactor (Plasmapp, South Korea) for decontamination and activation of the surface. In order to restrict any post-treatment contamination; abutments will be inserted immediately after the end of the plasma process.
Interventions
the test group were placed in an Argon plasma reactor
Eligibility Criteria
You may qualify if:
- presence of at least 4 mm of keratinized mucosa around the implants,
- patients aged 18 years or older
- medically healthy patients (ASA I), or patients with mild systemic disease (ASA II)
- Total or partial edentulous state with space for at least 2 implants
You may not qualify if:
- ASA physical status 3
- severe smokers (\> 10 cig/day)
- patients undergoing bisphosphonate therapy
- pregnant or lactating women
- estrogen-related hormonal disorders or hormonal substitution therapy patients with a history of head and neck cancers and radiotherapy in this region
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Canullo L, Donato A, Savadori P, Radovanovic S, Iacono R, Rakic M. Effect of argon plasma abutment activation on soft tissue healing: RCT with histological assessment. Clin Implant Dent Relat Res. 2024 Feb;26(1):226-236. doi: 10.1111/cid.13286. Epub 2023 Oct 18.
PMID: 37853303BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
July 5, 2025
First Posted
July 16, 2025
Study Start
July 15, 2025
Primary Completion
October 30, 2025
Study Completion
October 30, 2025
Last Updated
July 16, 2025
Record last verified: 2025-07